Disclosed is a moisture curable silane modified terpolymer comprising a polyether segment, a segment of polytetrahydrofuran or polycarbonate, a polysiloxane segment and terminal amino silane groups joined to the terpolymer via urethane linkages and wherein the polyether segment comprises at least 70% by weight based on the total weight of the silane modified terpolymer. Also disclosed is a method of forming moisture curable silane modified terpolymer.

The invention relates to a method for producing a polymer which contains organooxysilyl end groups. The method first has the step of reacting a polyoxyalkylene polyol which contains carbon-carbon multiple bonds with a organooxysilyl compound of the formula Si(X)n(R)4-n in the presence of a catslyst, wherein X independently of one another represents C1-C8-alkoxy, C7-C20-aralkoxy, C6-C14-aroxy, C7-C20-alkylaroxy, C1-C20-acyloxy; R independently of one another represents a saturated or unsaturated C1-C22-alkyl, C6-C14-aryl, C7-C14-aralkyl, C7-C14-alkylaryl; and n is 2, 3, or 4. The invention additionally relates to a method for producing an elastomer precursor from the polymer which contains organooxysilyl end groups and to products which can be obtained using said method.

A biocompatible nerve conduit for nerve re-generation, wherein a porous fiber tube is coated with a bioresorbable hydrogel, with the fibers being formed from a polymer that supports nerve regeneration by preferential adsorption of endogenous proteins and braided with pores in the range from 5 to 200 micrometers using a kink-resistant braiding pattern and the hydro gel coating material and thickness being selected to control the overall porosity, so that nutrients and oxygen can diffuse through said hydrogel coating but the infiltration of fibrous tissue through the coating is prevented.

A polycarbonate resin composition containing 0.1 to 10 parts by mass of a polycarbonate copolymer (B) having carbonate bonding between (B1) bisphenol A and a (B2) polyalkylene glycol and 0.005 to 0.5 parts by mass of a phosphorus-containing stabilizer (C) relative to 100 parts by mass of a polycarbonate resin (A).

A polyether carbonate polyol with a nominal functionality of 3 or more includes an equivalent molecular weight between 20,000 and 500,000 Da, and content of between 0.5 wt % and 35 wt % of CO.sub.2 based on the total weight of the polyether carbonate polyol. The polyether carbonate polyol has adhesive and impact modifying properties.

The invention relates to carbonate-linked surface modifying macromolecules and admixtures thereof. The admixtures can be used in industrial and medical applications where enhanced surface properties are desirable (e.g., surface properties reducing or preventing biofouling, immobilization of biomolecules, or denaturation of certain biomolecules).

A polycarbonate diol is provided, including three kinds of repeating diol units, wherein one of the repeating diol units is chosen from an alkoxylated diol monomer.

The present invention relates to the use of diblock copolymers as surfactants, and to a method for producing diblock copolymers, containing a hydrocarbon-containing block A and a polyether carbonate-containing block B, by attaching alkylene oxide and carbon dioxide to H-functional starters in the presence of a double metal cyanide catalyst, characterized in that the H-functional starter has an OH functionality of 1, and the H-functional starter is selected from one or more compounds of the group of monofunctional alcohols having 10 to 20 carbon atoms, and no further catalyst is used in addition to the DMC catalyst.

Disclosed in the present disclosure is a biodegradable amphiphilic polymer containing disulfide in the side chain, a self-crosslinked polymeric vesicle thereof and an application in the targeted therapy of lung cancer. The polymer is obtained by an activity-controllable ring-opening polymerization based on a cyclic carbonate monomer containing a functional group of dithiolane ring, which has a controllable molecular weight and a narrow molecular weight distribution, and does not require processes of protection and deprotection; the polymer obtained by the ring-opening polymerization of the cyclic carbonate monomer of the present disclosure has biodegradability and can be used to control the drug release system, the prepared lung cancer-targeted reduction-sensitive reversibly-crosslinked polymeric vesicle as a nanomedicine carrier supports stable long circulation in vivo. However, it is highly enriched in lung cancer tissues, enter cells efficiently, and rapidly decrosslinks in the cells to release drugs, so as to kill cancer cells with high potency and specificity and inhibit the growth of tumor effectively without causing toxic and side effects.

The present invention relates to a method for preparing poly(carbonate-etherimide) compound comprising polycarbonate segment as shown in the structure (A) and polyetherimide segment as shown in the structure (B). Said method does not contain a highly toxic phosgene in its operation, can be performed easily, and can be operated at not high temperature. wherein R.sub.1 represents aromatic with 6 to 30 carbon atoms or, optionally said aromatic is bonded with heteroatom; R.sub.2 represents aromatic with 6 to 30 carbon atoms or, optionally said aromatic is bonded with heteroatom; m is an integer from 1 to 15; and n is an integer from 1 to 10. ##STR00001##